Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-05-25T23:37:12.026Z Has data issue: false hasContentIssue false

Creutzfeldt-jacob disease with psychiatric presentation (CJD) : A case report

Published online by Cambridge University Press:  16 April 2020

P. Zeppegno
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
R. Cantello
Affiliation:
Department of Clinical and Experimental Medicine, Clinical Neurophysiology, University of Eastern Piedmont ‘A. Avogadro’, Novara, Italy
A. Lombardi
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
A. Feggi
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy
E. Torre
Affiliation:
Department of Clinical and Experimental Medicine, Institute of Psychiatry, University of Eastern Piedmont, Novara, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

CJD is a neurodegenerative disease with a rapid onset characterized by progressive dementia, myoclonus and also cerebellar, pyramidal and extrapyramidal signs. It is caused by an increased loss of neurons due to the abnormal conformation of a membrane protein.

Case report

A 69 year-old woman was admitted to Psychiatry with a clinical picture characterized by psychomotor agitation, disorientation, confusion, confabulation, false ricognition, circumstantiality, perseveration, logorrhea and dysphoria. She presented no alterations of sense-perception. Her psychiatric history was silent. The neurological examination showed no focal neurological deficits and the first EEG was nonspecific. She became progressively more confused, with subsequent drowsiness with psychomotor agitation, aimless buste, disorganization and visual hallucinations. She started treatment with quetiapine (200 mg/die) and lorazepam (4 mg/die) without benefit. The second EEG was characterized by triphasic waves with diffuse projection. MRI angiography revealed the presence of diffuse cortical ribbon hyperintensity of gray matter. CSF examination showed positivity of 14/3/3 protein and a TAU protein value greater than 16000 pq/ml allowing diagnosis of CJD.

Conclusions

We emphasize the importance of a correct differential diagnosis in patients with psychiatric symptoms and rapidly progressive dementia unresponsive to therapy.

Type
P03-50
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.